Researchers find clue to safer obesity drugs
The cost of treating colorectal cancer varies widely, with newer, life-extending therapies sometimes costing tens of thousands of dollars more than older agents, according to a study led by a team of researchers in the Duke Comprehensive Cancer Center. “The total cost of chemotherapy to treat colorectal cancer may differ by as much as $36,999
Full Post: Cost of treating colorectal cancer varies widely
Once hailed as a miracle weight-loss drug, Fen-phen was removed from the market more than a decade ago for inducing life-threatening side effects, including heart valve lesions. Scientists at UT Southwestern Medical Center are trying to understand how Fen-phen behaves in the brain in order to develop safer anti-obesity drugs with fewer side effects.
In a study appearing in the Nov. 25 issue of Neuron, the researchers define a circuit in the brain that explains the ways fenfluramine, a component of Fen-phen, suppresses appetite.
“Our findings provide evidence that the neural circuit we’ve proposed is sufficient for the neurotransmitter serotonin to regulate food intake and body weight, ” said Dr. Joel Elmquist, professor of internal medicine and pharmacology at UT Southwestern and senior author of the study. “Fen-phen works directly on this pathway. Unfortunately, that drug also adversely affects peripheral tissue such as the heart.”
For the current study, the researchers engineered mice in which the expression of a serotonin receptor called 5-hydroxytryptamine 2C was blocked throughout the entire body. This was previously known to produce obese mice resistant to the anorexic actions of fenfluramine. When activated by serotonin, however, this receptor is also known to suppress appetite. Using this mouse model, the authors engineered another set of mice in which the same serotonin receptor was blocked everywhere in the body except within a group of brain cells called pro-opiomelanocortin, or POMC, neurons. The POMC neurons, which are found in the hypothalamus, are also known to play an important role in suppressing appetite and inducing weight loss.
The researchers found that the animals with no serotonin 2c receptors expectedly developed obesity as well as other metabolism disorders such as increased food intake, hyperactivity and leptin insensitivity. They also were prone to spontaneous seizures, said Dr. Elmquist.
In contrast, the mice in which the serotonin receptor was re-expressed and functioning only in the POMC neurons stayed slim and responded to fenfluramine.
“The POMC-specific reactivation of the receptor only in POMC neurons normalizes the abnormal metabolism in these mice,” Dr. Elmquist said. “The animals don’t eat excessively. Their hyperactivity is also gone.”
Previous work from the UT Southwestern group led to the hypothesis that Fen-phen worked by activating the serotonin 2c receptor in the POMC neurons in the hypothalamus. The current work provides genetic proof supporting this model.
“Conventional wisdom is that fenfluramine increases serotonin release that then activates serotonin receptors in the brain to regulate food intake and body weight, but unfortunately, this drug also causes lesions in heart valves,” he said. “If you could develop a drug that would travel to both the brain and the peripheral tissues, and then give a blocker to protect the heart, it’s possible that you could prevent the harmful side effects and still aid weight loss. Admittedly, that’s a bit farfetched, but this mouse model could be used to test that theory.”
The team’s next step is to determine whether they’ve identified the sole circuit required to suppress appetite and induce weight loss.
Other UT Southwestern scientists involved in the research were Drs. Yong Xu, Daisuke Kohno and Kevin Williams, postdoctoral research fellows in internal medicine; Charlotte Lee, senior research scientist; Michelle Choi, research assistant in internal medicine; Jason Anderson, student research assistant; and Dr. Jeffrey Zigman, assistant professor of internal medicine. Researchers from the University of Cambridge and Harvard Medical School also contributed.
The work was funded by the National Institutes of Health, Canadian Institute of Health, American Diabetes Association, Smith Family Foundation and Wellcome Trust.
Genetic mouse models have provided surprising insight into mechanisms linking serotoninergic compounds with the regulation of feeding behavior and body weight. The research, published by Cell Press in the November 26th issue of the journal Neuron , pinpoints a specific group of brain cells that mediate energy balance and may lead to the development of
Full Post: Discovery of mechanism linking serotonin with regulation of food intake
In the battle against obesity, Yale University researchers may have discovered a new weapon - a naturally occurring molecule secreted by the gut that makes rats and mice less hungry after fatty meals. The findings are published in the Nov. 26 issue of the journal Cell . The report suggests the molecule may help regulate
Full Post: Yale researchers find molecule that may help regulate how much animals and people eat
Shredded extracellular matrix (ECM) is toxic to neurons. Chen et al. reveal a new mechanism for how ECM demolition causes brain damage. The study will appear in the December 29, 2008 issue of The Journal of Cell Biology (www.jcb.org). A stroke or head injury kills large numbers of neurons through a process called excitotoxicity. A
Full Post: Matrix fragments trigger fatal excitement
When it comes to remodeling our bones-an ongoing process of break down and renewal that goes on throughout adulthood–researchers have new evidence that our guts play a surprisingly important role. The findings point toward novel methods for increasing bone mass in patients with diseases characterized by impaired bone formation, including postmenopausal osteoporosis, according to the
Full Post: Gut found to exert control over bone
Researchers at UT Southwestern Medical Center have uncovered new insights into the “Dr. Jekyll and Mr. Hyde” nature of a protein that stimulates stem-cell maturation in the brain but, paradoxically, can also lead to nerve-cell damage. In two separate studies in mice scheduled to appear online this week and in an upcoming issue of the
Full Post: Researchers uncover beneficial mechanism of the helpful “Dr. Jekyll” side of the Cdk5 protein